CRISTINA SOLA-ROTGER: Open Payments
NPI 1447892674 · ESSEX, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$427 in 19 payments from 8 companies in 2025. Trend: 2023 $224 · 2024 $378 · 2025 $427
Food & beverage: $427
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 3 | $127 |
| Novo Nordisk Inc | 4 | $84 |
| AstraZeneca Pharmaceuticals LP | 3 | $58 |
| Exact Sciences Corporation | 3 | $53 |
| Astellas Pharma US Inc | 3 | $51 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
Products named: Dexcom G6 Transmitter, Rybelsus, BREZTRI, Cologuard Collection Kit, Veozah, GEMTESA, JARDIANCE, Kerendia.
Industry payments across MD — which companies pay providers there.
